Colonic Drug Delivery

References

• Macheras P., Reppas C., Dressman J. B. 5. Biopharmaceutics of Orally Administered Drugs. Ellis Horwood, Chichester 1989, Chapter
   Google Scholar
• Steed K. P., Wilson C. G., Washington N. Drug delivery to the large intestine, Chapter 9. Physiological Phamceutics—Biological Bariers to Drug Absolption, C. G. Wilson, N. Washington. Ellis Horwod, Chichester 1989
   Google Scholar
• Binder H. J., Sandle G. I. Electrolyte absorption in the mammalian colon, Chapter 64. Physiology of the Gastrointestinal Tract, 3rd ed., L. R. Johnson. Raven Press, New York 1994
   Google Scholar
• Cummings J. H., Banwell J. G., Segal I., Coleman N., Englyst H. N., Macfarlane G. T. The amount and composition of large bowel contents. Gastroenterology 1990; 98: A408
   Google Scholar
• MacFarlane G. T., Cummings J. H. The colonic flora, fermentation and large bowel digestive function, Chapter 4. The Large Intestine: Physiology, Patho-physiology, and Disease, S. F. Phillips, J. H. Pemberton, R. G. Shorter. Raven Press, New York 1991
   Google Scholar
• Evans D. F., Pye G., Bramley R., Clark A. G., Dyson T. J., Hardcastle J. D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988; 29: 1035–1041
   PubMed Web of Science ®Google Scholar
• Avery G. S., Davies E. F., Brogden R. N. Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action in portal system encephalopathy. Drugs 1972; 4: 7–48
   PubMed Web of Science ®Google Scholar
• Tomlin J., Read N. W. The relation between bacterial degradation of viscous polysaccharides and stool output in human beings. Br. J. Nutr. 1988; 60: 467–475
   PubMed Web of Science ®Google Scholar
• Raimundo A. H., Evans D. F., Rogers J., Silk D. B. A. Gastrointestinal pH profiles in ulcerative colitis. Gastroenterology 1992; 104: A681
   Google Scholar
• Kaus L. C., Fell J. T., Sharma H., Taylor D. C. On the intestinal transit of a single nondisintegrating object. Int. J. Pharm. 1984; 14: 143–148
   Google Scholar
• Davis S. S., Hardy J. G., Stockwell A., Taylor M. J., Whalley D. R., Wilson C. G. The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet). Int. J. Pharm. 1984; 21: 331–340
   Web of Science ®Google Scholar
• Wilson C. G., Washington N., Greaves J. L., Kamali F., Rees J. A., Sempik A. K., Lampard J. F. Bimodal release of ibuprofen in a sustained-release formulation: a scintigraphic and pharmacokinetic open study in healthy volunteers under different conditions of food intake. Int. J. Pharm. 1989; 50: 155–161
   Web of Science ®Google Scholar
• Davis S. S., Hardy J. G., Fara J. W. Transit of pharmaceutical dosage forms through the small intestine. Gut 1986; 886–892
   PubMed Web of Science ®Google Scholar
• Bararow L., Spiller R. C., Wilson C. G. Pathological influences on colonic motility: implications for drug delivery. Adv. Drug Del. Rev. 1991; 7: 201–220
   Web of Science ®Google Scholar
• Metcalf A. M., Phillips S. F., Zinsmeister A. R., MacCart R. L., Beart R. W., Wolff B. G. Simplified assessment of segmental colonic transit. Gastroenterol-ogy 1987; 92: 40–47
   PubMed Web of Science ®Google Scholar
• Hinds J. P., Stoney B., Wald A. Does gender or the menstrual cycle affect colonic transit? Am. J. Gastroenterol. 1989; 84: 123–126
   Google Scholar
• Wyman J. B., Heatin K. W., Manning A. P., Wicks A. C. B. Variability of colonic function in healthy subjects. Gut 1978; 19: 146–150
   PubMed Web of Science ®Google Scholar
• Khosla R., Davis S. S. Gastric emptying and small and large bowel transit of nondisintegrating tablets in fasted subjects. Int. J. Pharm. 1989; 52: 1–10
   Google Scholar
• Davis S. S., Washington N., Parr G. D., Short A. H., John V. A., Lloyd P., Walker S. M. Relationship between the appearance of oxprenolol in the systemic circulation and the location of an oxprenolol 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy. Br. J. Clin. Pharmacol. 1988; 26: 435–443
   PubMed Web of Science ®Google Scholar
• Proano M., Camilleri M., Phillips S. F., Brown M. L., Thomforde G. M., Tucker R. L. Unprepared human colon does not discriminate between solids and liquids. Am. J. Physiol. 1991; 260, (Gastrointest. Liver Physiol., 23) G13–16
   PubMed Web of Science ®Google Scholar
• Proano M., Camilleri M., Phillips S. F., Brown M. L., Thomforde G. M. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am. J. Physiol. 1990; 258, (Gastrointest. Liver Physiol., 21) G856–862
   PubMed Web of Science ®Google Scholar
• Parker G., Wilson C. G., Hardy J. G. The effect of capsule size and density on transit through the proximal colon. J. Pharm. Pharmacol. 1988; 40: 376–377
   PubMed Web of Science ®Google Scholar
• Hardy J. G., Wilson C. G., Wood E. Drug delivery to the proximal colon. J. Pharm. Pharmacol. 1985; 37: 874–877
   PubMed Web of Science ®Google Scholar
• Watts P. J., Barrow L., Steed K. P., Wilson C. G., Spiller R. C., Melia C. D., Davies M. C. The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis. Int. J. Pharm. 1992; 87: 215–221
   Web of Science ®Google Scholar
• Adkin D. A., Davis S. S., Sparrow R. A., Wilding I. R. Colonic transit of different sized tablets in healthy subjects. J. Control. Rel. 1993; 23: 147–156
   Web of Science ®Google Scholar
• Cummings J. H., Branch J. W., Jenkins D. J. A., Southgate D. A. T., Houston H., James W. P. T. Colonic response to dietary fibre from carrot, cabbage, apple, bran and guar gum. Lancet 1978; 1: 5–9
   PubMed Web of Science ®Google Scholar
• Price J. M. C., Davis S. S., Wilding I. R. The effect of fibre on gastrointestinal transit times in vegetarians and omnivores. Int. J. Pharm. 1991; 76: 123–131
   Web of Science ®Google Scholar
• Price J. M. C., Davis S. S., Sparrow R. A., Wilding I. R. The effect of meal composition on the gastrocolonic response: implications for drug delivery to the colon. Pharm. Res. 1993; 10: 722–726
   PubMed Web of Science ®Google Scholar
• Longe R. L., DiPiro J. T. Diarrhea and constipation, Chapter 30. Pharmacotherapy - A Pathophysiologic Approach, J. T. DiPiro, R. L. Talbert, P. E. Hayes, G. C. Yee, L. M. Posey. Elsevier, New York 1989
   Google Scholar
• Brunton L. Drugs affecting gastrointestinal function, Section VI. Goodman & Gilman 's The Phamcological Basis of Therapeutics, 9th ed., J. G. Hardman, Goodman A. Gilman, L. E. Limbird. McGraw Hill, New York 1996
   Google Scholar
• Gaska J. A., Sarafpour B. Update on inflammatory bowel disease 1989; 200: 64–74
   Google Scholar
• Thompson W. G. Irritable bowel syndrome, Chapter 29 in The Large Intestine: Physiology. Pathophysiology and Disease, S. F. Phillips, J. H. Pemberton, R. G. Shorter. Raven Press, New York 1991
   Google Scholar
• Hardy J. G., Davis S. S., Khosla R., Robertson C. S. Gastrointestinal transit of small tablets in patients with ulcerative colitis. Int. J. Pharm. 1988; 48: 79–82
   Web of Science ®Google Scholar
• Barrow L., Steed K. P., Spiller R. C., Watts P. J., Melia C. D., Davies M. C., Wilson C. G. Scintigaphic demonstration of colonic transit by lactulose and its modification by gelling agents. Gastro-enterology 1992; 103: 1167–1173
   PubMedGoogle Scholar
• Barrow L., Steed K. P., Spiller R. C., Maskell N. A., Brown J. K., Watts P. J., Melia C. D., Davies M. C., Wilson C. G. Quantitative, noninvasive assessment of antidiarrheal actions of codeine using an experimental model of diarrhoea in man. Dig. Dis. Sci. 1993; 38: 996–1003
   PubMed Web of Science ®Google Scholar
• Smith P. L., Wall D. A., Gochoco C. H., Wilson G. Oral absorption of peptides and proteins. Adv. Drug. Dei. Rev. 1992; 8: 253–290
   Web of Science ®Google Scholar
• Wilson C. G., Washington C., Washington N. Small intestine: tranasit and absorption of drugs, Chapter 5. Physiological Phamceutics - Biologicul Barriers to Drug Absorption, C. G. Wilson, N. Washington. Ellis Horwood, Chichester 1989
   Google Scholar
• Taylor D. C., Lynch J., Leahy D. E. Models for intestinal permeability to drugs, Chapter 11. Drug Delivery to the Gastrointestinal Tract, J. G. Hardy, S. S. Davis, C. G. Wilson. Ellis Horwood, Chichester 1989
   Google Scholar
• Powell D. W. Barrier function of epithelia. Am. J. Physiol., 241, (Gastrointest. Liver Physiol., 4), G275-G288, 1981
   Web of Science ®Google Scholar
• Brockmeier D., Grigoleit H. G., Leonhardt H. Absorption of glibenclamide from different sites of the gastrointestinal tract. Eur. J. Clin. Pharmac. 1985; 29: 193–197
   PubMed Web of Science ®Google Scholar
• Gleiter C. H., Antonin K. H., Bieck P., Godbillon J., Schönleber W. Colonoscopy in the investigation of drug absorption in healthy volunteers. Gastrointest. Endosc. 1985; 31: 71–73
   PubMed Web of Science ®Google Scholar
• Staib A. H., Loew D., Harder S., Grayl E. H., Pfab R. Measurement of theophylline absorption from different regions of the gastrointestinal tract using a remote controlled drug delivery device. Eur. J. Clin. Pharmac. 1986; 9: 95–97
   Google Scholar
• Godbillon J., Evard D., Vidon N., Duval M., Schoeller J. P., Bernier J. J., Hirtz J. Investigation of drug absorption from the gastrointestinal tract of man. 111. Metoprolol in the colon. Br. J. Clin. Pharmac. 1985; 19: 113S–118s
   PubMed Web of Science ®Google Scholar
• Antonin K. H., Bieck P., Scheurlen M., Jedrychowski M., Malchow H. Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing. Br. J. Clin. Pharmac. 1985; 19: 137s–142s
   PubMed Web of Science ®Google Scholar
• Bieck P. R. Drug absorption from the human colon, Chapter 12. Drug Delivery to the Gastrointestinal Tract, J. G. Hardy, S. S. Davis, C. G. Wilson. Ellis Horwood, Chichester 1989
   Google Scholar
• Brockmeier D., Grigoleit H. G., Leonhardt H. The absorption of piretanide from the gastrointestinal tract is site-dependent. Eur. J. Clin. Pharmac. 1986; 30: 79–82
   PubMed Web of Science ®Google Scholar
• Wilson C. G., Washington N., Greaves J. L., Washington C., Hoadley T., Sims E. E. Predictive modelling of the behavior of a controlled-release buflomedil HC1 formulation using scintigraphic and pharmacokinetic data. Int. J. Pharm. 1991; 72: 79–86
   Google Scholar
• Riley S. A., Kim M., Sutcliffer F., Rowland M., Turnberg L. A. Absorption of polar drugs following caecal instillation in healthy volunteers. Aliment. Pharmacol. Ther. 1992; 6: 701–706
   PubMed Web of Science ®Google Scholar
• Erlich B. E., Diamond J. M. Lithium absorption: implications for sustained release lithium preparations. Lancet 1983; 1: 306
   Web of Science ®Google Scholar
• Staib A. H., Beerman D., Harder S., Fuhr U., Liermann D. Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). Am. J. Med. 1989; 87: 66s–69s
   PubMed Web of Science ®Google Scholar
• Watanabe Y., Sano M., Motohashi K., Yoneda R., Mitsui Y., Botan Y. Relationship between quality and serum level after the oral administration of commercial erythromycin tablets in man. Y. Zasshi 1977; 97: 791–800
   Google Scholar
• Garnder M. L. G. Absorption of intact proteins and peptides. Chapter 53. Physiology of fhe gastrointestinal tract, 3rd ed., L. R. Johnson. Raven Press, New York 1994
   Google Scholar
• Martindale. The Extra Pharmacopoeia, 31st ed., J. E. F. Reynolds. Royal Pharmaceutical Society, London 1996; 1279
   Google Scholar
• Moore J. A., Pletcher S. A., Ross M. J. Absorption enhancement of growth hormone from the gastrointestinal tract of rats. Int. J. Pharm. 1986; 34: 35–43
   Web of Science ®Google Scholar
• Kraeling M. E. K., Ritschel W. A. Development of a colonic release capsule dosage form and the absorption of insulin. Meth. Find. Exp. Clin. Pharmacol. 1992; 14: 199–209
   PubMed Web of Science ®Google Scholar
• Rao S. S., Ritschel W. A. Development and in vitrolin vivo evaluation of a colonic release capsule of vasopressin. Int. J. Pharm. 1992; 86: 35–41
   Web of Science ®Google Scholar
• Hastewell J., Lynch S., Williamson I., Fox R., Mackay M. Absorption of human calcitonin across the rat colon in vivo. Clin. Sci. 1992; 82: 589–594
   PubMed Web of Science ®Google Scholar
• Langguth P., Breves G., Stockli A., Merckle H. P., Wolffram S. Colonic absorption and bioavailability of the pentapeptide metkephamid in the rat. Pharm. Res. 1994; 11: 1640–1645
   PubMed Web of Science ®Google Scholar
• Fisher A. N., Illum L., Davis S. S., Haresign W., Jabbal-Gill J., Hinchcliffe M. Use of a pig model for colon specific delivery of peptides, proteins and other drugs, in Minutes from. European Symposium on Formulation of Poorly-Available Drugs for Oral Administration. Editions de Santé, Paris 1996; 183–186
   Google Scholar
• Antonin K. H., Saano V., Bieck P., Hastewell J., Fox R., Lowe P., Mackay M. Colonic absorption of human calcitonin in man. Clin. Sci. 1992; 83: 627–631
   PubMed Web of Science ®Google Scholar
• Hastewell J., Antonin K. H., Fox R., Mackay M. The colonic absorption of human calcitonin: the effects of increasing local concentration and co-administration with a protease inhibitor. Int. J. Pharm. 1995; 126: 245–251
   Google Scholar
• Antonin K. H., Rak R., Bieck P. R., Preiss R., Schenker U., Hastewell J., Fox R., Mackay M. The absorption of human calcitonin from the transverse colon of man. Int. J. Pharm. 1996; 130: 33–39
   Web of Science ®Google Scholar
• Kim J. S., Oberle R. L., Krummel D. A., Dressman J. B., Fleisher D. Absorption of ACE inhibitors from small intestine and colon. J. Pharm. Sci. 1994; 83: 1350–1356
   PubMed Web of Science ®Google Scholar
• Swenson E. S., Curatolo W. J. Intestinal permeability enhancement for proteins, peptides, and other polar drugs: mechanisms and potential toxicity. Adv. Drug. Del. Rev. 1992; 8: 39–92
   Web of Science ®Google Scholar
• Sayani A. P., Chein Y. W. Systemic delivery of peptides and proteins across absorptive mucosae. Crit. Rev. Ther. Drug Carr. Syst. 1996; 13: 85–184
   PubMed Web of Science ®Google Scholar
• Hastewell J., Lynch S., Fox R., Williamson I., Skelton-Stroud P., Mackay M. Enhancement of human calcitonin absorption across the rat colon in vivo. Int. J. Pharm. 1994; 101: 115–120
   Web of Science ®Google Scholar
• FASS. Läkemedel i Sverige. Läkemedel-sinformation AB, Sweden 1995, 1995
   Google Scholar
• Gwinup G., Elias A. N., Domurat E. S. Insulin and c-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules. Gen. Pharmac. 1991; 22: 243–246
   PubMedGoogle Scholar
• Scrip 1996; 2116, 13; 2133, p. 27; 2146, p. 23; 2163, p. 21
   Google Scholar
• Jay M., Digenis G. A., Foster T. S., Antonow D. R. Retrograde spreading of hydrocortisone enema in inflammatory bowel disease. Dig. Dis. Sci. 1986; 31: 139–144
   PubMed Web of Science ®Google Scholar
• Hardy J. G., Lee S. W., Clark A. G., Reynolds J. R. Enema volume and spreading. Int. J. Pharm. 1986; 31: 151–155
   Web of Science ®Google Scholar
• Farthing M. J. G., Rutland M. D., Clark M. L. Retrograde spread of hydrocortisone-containing foam given rectally in ulcerative colitis. Br. Med. J. 1979; 2: 822–824
   PubMed Web of Science ®Google Scholar
• Campieri M., Lanfranchi G. A., Brignola C., Bazzochi G., Gionchetti P., Minguzzi M. R., Cappello I. P., Corbelli C., Boschi S. Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis. Dis. Colon and Rectum 1986; 29: 108–110
   PubMed Web of Science ®Google Scholar
• Klotz U. Clinical pharmacokmetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin. Pharmacokinetics 1985; 10: 285–302
   PubMed Web of Science ®Google Scholar
• Lloyd A. W., Hodges N. A., Martin G. P., Soozandehfat S. H. Azo reduction is mediated by enzymati-cally generated low molecular weight electron carriers. J. Pharm. Phannacol. 1993; 45: 21P
   PubMedGoogle Scholar
• Peppercorn M. A. Sulfasalazine: pharmacology, clinical use, toxicity and related new drug development. Ann. Intern. Med. 1984; 3: 377–386
   Web of Science ®Google Scholar
• Jarnerot G. Newer 5-aminosalicylic acid pased drugs in chronic inflammatory bowel disease. Drugs 1989; 37: 73–86
   PubMed Web of Science ®Google Scholar
• Campbell D. E. S., Berlingdh T. Pharmacology of olsalazine. Scand. J. Gastroenterol. 1988; 23(b)7–12
   PubMedGoogle Scholar
• Sandberg-Gertzen H., Ryde M., Jarnerot G. Long-term treatment with olsalazine for ulcerative colitis: safety and relapse prevention. A follow-up study. Scand. J. Gastroenterol. 1988; 23(b)48–50
   Google Scholar
• Willoughby C. P., Cowan R. E., Could S. R., Machell R. J., Stewart J. B. Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis. Scand. J. Gastroenterol. 1988; 23(b)40–44
   Google Scholar
• Chan R. P., Pope D. J., Gilbert A. P., Sacra P. J., Baron J. H., Lennard-Jones J. E. Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide. Dig. Dis. Sci. 1983; 28: 609–716
   PubMed Web of Science ®Google Scholar
• Brown J. P., McGarraug G. V., Parkinson T. M., Wingard R. E., Onderdonk A. B. A polymeric drug for treatment of inflammatory bowel disease. J. Med. Chem. 1983; 26: 1300–1307
   PubMed Web of Science ®Google Scholar
• Schacht E., Gevaert A., Kenawy E. R., Molly K., Verstraete W., Adriaensens P., Carleer R., Gelan J. Polymers for colon specific drug delivery. J. Control. Rel. 1996; 39: 327–338
   Web of Science ®Google Scholar
• Kopeckova P., Rathi R., Takada S., Rihova B., Berenson M. M., Kopecek J. Bioadhesive N-(2-hydroxypropyl) methacrylamide copolymers for colons-specific drug delivery. J. Control. Rel. 1994; 28: 211–222
   Web of Science ®Google Scholar
• Saffran M., Kumar G. S., Savariar C., Bumham J. C., Williams F., Neckers D. C. A new approach to the oral administration of insulin and other peptide drugs. Science 1986; 233: 1081–1084
   PubMed Web of Science ®Google Scholar
• Lloyd A. W., Martin G. P., Soozandehfar S. H. Azopolymers: a means of colon specific drug delivery? Int. J. Pharm. 1994; 106: 255–260
   Google Scholar
• Hastewell J., Phillips J., Lloyd A. W., Martin G. P., Marriott C., Williams M. The evaluation of microbially activated colonic drug delivery systems. J. Pharm. Pharmacol. 1991; 43: 61P
   Google Scholar
• Lloyd A. W., Hodges N. A., Martin G. P., Marriott C., Williams M., Hastewell J., Phillips J. Studies of azopolymer based drug delivery systems. Proc. Ann. UKaps Conf. 1992; 1: 218
   Google Scholar
• Van den Mooter G., Samyn C., Kinget R. Azo polymers for colon-specific drug delivery. Int. J. Pharm. 1992; 87: 37–46
   Web of Science ®Google Scholar
• Van den Mooter G., Samyn C., Kinget R. Azo polymers for colons-specific drug delivery. 11. Influence of the type of azo polymer on the degradation by intestinal microflora. Int. J. Pharm. 1993; 97: 133–139
   Web of Science ®Google Scholar
• Kimura Y., Makita Y., Kumagai T., Yamane H., Kitao T., Sasatani H., Kim S. I. Degradation of azo-containing polyurethane by the action of intestinal flora: its mechanism and application as a drug delivery system. Polymer 1992; 33: 5294–5299
   Web of Science ®Google Scholar
• Kopecek J., Kopeckova P., Brondsted H., Rathi R., Rihova B., Yeh P.-Y., Ikesue K. Polymers for colon-specific drug delivery. J. Control. Rel. 1992; 19: 121–130
   Web of Science ®Google Scholar
• Schacht E., Wilding I. R. Process for the preparation of azo- and/or disulphide-containing polymers, patent application PCT/BE91/00006. 1991
   Google Scholar
• Friend D. R., Chang G. W. A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. J. Med. Chem. 1984; 27: 261–266
   PubMed Web of Science ®Google Scholar
• Friend D. R., Chang G. W. Potential prodrugs for colon-specific drug delivery. J. Med. Chem. 1985; 28: 51–57
   PubMed Web of Science ®Google Scholar
• Friend D. R., Tozer T. N. Drug glycosides in oral colon-specific drug delivery. J. Control. Rel. 1992; 19: 109–120
   Web of Science ®Google Scholar
• Kimura T., Yamaguchi T., Kurosaki Y., Nakayama T., Fujiwara Y., Unno K., Suzuki T. Design and evaluation of colonic mucosa-specific pro-antedrugs for oral treatment of ulcerative colitis. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 1991; 18: 427–428
   Google Scholar
• Milojevic S., Newton J. M., Cummings J. H., Gibson G. R., Botham R. L., Ring S. G., Stockham M., Allwood M. C. Amy lose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets. J. Control. Rel. 1996; 38: 75–84
   Web of Science ®Google Scholar
• Milojevic S., Newton J. M., Cummings J. H., Gibson G. R., Botham R. L., Ring S. G., Stockham M., Allwood M. C. Amy lose as a coating for drug delivery to the colon: preparation and in vitro evaluation using glucose pellets. J. Control. Rel. 1996; 38: 85–94
   Web of Science ®Google Scholar
• Ashford M., Fell J., Attwood D., Sharma H., Woodhead P. An evaluation of pectin as a carrier for drug targeting to the colon. J. Control. Rel. 1993; 26: 213–220
   Web of Science ®Google Scholar
• Ashford M., Fell J., Attwood D., Sharma H., Woodhead P. Studies on pectin formulations for colonic drug delivery. J. Control. Rel. 1994; 30: 225–232
   Web of Science ®Google Scholar
• Wakerly Z., Fell J. T., Attwood D., Parkins D. Pectin/ethylcellulose film coating formulations for chronic drug delivery. Pharm. Res. 1996; 13: 1210–1212
   PubMed Web of Science ®Google Scholar
• Rubinstein A., Radai R., Ezra M., Pathak S., Rokem J. S. In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier. Pharm. Res. 1993; 10: 258–263
   PubMed Web of Science ®Google Scholar
• Kenyon C., Nardi R., Wong D., Hooper G., Wilding I., Friend D. Colonic delivery of dexametha-sone: a pharmacoscintigraphic clinical evaluation. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 1996; 23: 553–554
   Google Scholar
• Lehmann K. O. R., Dreher K. D. Methacrylate-galactomannan coating for colon-specific drug delivery. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 1991; 18: 331–332
   Google Scholar
• Hirsch S., Schehlmann V., Kolter K., Betzing J., Bauer K. H. In vitro testing of crosslinked galacto-mannan coated tablets for site-specific drug delivery to the colon. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 1995; 22: 264–265
   Google Scholar
• Rubinstein A., Nakar D., Sintov A. Colonic drug delivery: enhanced release of indomethacin from cross-linked chondroitin matrix in rat cecal content. Pharm. Res. 1991; 9: 276–278
   Web of Science ®Google Scholar
• Healey J. N. C. Enteric coatings and delayed release, Chapter 7. Drug Delivery to the Gastrointestinal Tract, J. G. Hardy, S. S. Davis, C. G. Wilson. Ellis Horwood, Chichester 1989
   Google Scholar
• Dew M. J., Hughes P. J., Lee M. G., Evans B. K., Rhodes J. Br. J. Clin. Pharmac. 1982; 14: 405–408, An oral preparation to release drugs in the human colon
   PubMed Web of Science ®Google Scholar
• Dew M. J., Ryder R. E. J., Evans N., Evans B. K., Rhodes J. Colonic release of 5-aminosalicylic acid from an oral preparation in active ulcerative colitis. Br. J. Clin. Pharmac. 1983; 16: 185–187
   PubMed Web of Science ®Google Scholar
• Schroeder K. W., Tremaine W. J., Ilstrup D. M. Coated 5-amonisalicylic acid therapy for mildly to moderately active ulcerative colitis. New Eng. J. Med. 1987; 317: 1625–1629
   PubMed Web of Science ®Google Scholar
• Hardy J. G., Healey J. N. C., Reynolds J. R. Evaluation of an enteric-coated delayed release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease. Aliment. Pharmacol. Therap. 1987; 1: 273–280
   PubMedGoogle Scholar
• Ashford M., Fell J. T., Attwood D., Woodhead P. J. An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting. Int. J. Pharm. 1993; 91: 241–245
   Web of Science ®Google Scholar
• Ashford M., Fell J. T., Attwood D., Sharma H., Woodhead P. J. An in vivo investigation into the suitability of pH-dependent polymers for colonic targeting. Int. J. Pharm. 1993; 95: 193–199
   Web of Science ®Google Scholar
• Watts P., 95/35100, 1995, Colonic drug delivery composition, patent application WO
   Google Scholar
• ‘Scherer DDS develops “alarm clock” dose formulation’. Pharmaceutical Journal 1991; 247: 138
   Google Scholar
• Binns J. S., Bakhshaee M., Miller C. J., Stevens H. N. E. Application of a pH independent PEG based hydrogel to afford pulsatile drug delivery. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 1993; 20: 226–227
   Google Scholar
• Wilding I. R., Davis S. S., Bakhshaee M., Stevens H. N. E., Sparrow R. A., Brennan J. Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation. Pharm. Res. 1992; 9: 654–657
   PubMed Web of Science ®Google Scholar
• Binns J., Stevens H. N. E., McEvwen J., Pritchard G., Brewer F. M., Clarke A., Johnson E. S., McMillan I. The tolerability of multiple doses of Pulsincap capsules in healthy volunteers. J. Control. Rel. 1996; 38: 151–158
   Web of Science ®Google Scholar
• Pozzi F., Furlani P., Gazzaniga A., Davis S. S., Wilding I. R. The TIME CLOCK system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. J. Control. Rel. 1994; 31: 99–108
   Web of Science ®Google Scholar
• Gazzaniga A., Iamartino P., Maffione G., Sangalli M. E. Oral delayed-release system for colonic specific delivery. Int. J. Pharm. 1994; 108: 77–84
   Web of Science ®Google Scholar
• Gazzaniga A., Busetti C., Moro L., Crimella T., Sangalli M. E., Giordano F. Evaluation of low viscosity HPMC as retarding coating material in the preparation of a time-based oral colon specific delivery system. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 1995; 22: 242–243
   Google Scholar
• Theeuwes F., Wong P., Burkoth T. L., Fox D. A. Osmotic systems for colon-targeted drug delivery, Chapter 7. Colonic Drug Absorption and Metabolism, P. Bieck. Marcel Dekker, New York 1993
   Google Scholar